Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer | Journal of Clinical Oncology
An institutional review: dosimetry comparison between simultaneous integrated boost IMRT and VMAT for prostate cancer | Journal of Radiotherapy in Practice | Cambridge Core
Selection of dosimetric quality parameters outlined in the CHHIP trial... | Download Table
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016) - European Urology Oncology
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial - The Lancet Oncology
Frontiers | Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial - ScienceDirect
Supplementary appendix
Jonathan Tomaszewski on Twitter: "First rectal dose constraints (for 3Gy/#) derived from CHHiP trial. Adopted as optimal constraints in ongoing trials (PACE-C, PIVOTALboost). https://t.co/CtCGBmQAHd #openaccess #pcsm #radonc https://t.co/5uFuaPTfeV ...
Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy Fractionation - ScienceDirect
Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy Fractionation - ScienceDirect
Selection of some of the relevant dosimetric quality parameters... | Download Table
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline | Journal of Clinical Oncology
Biology | Free Full-Text | Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
Practical considerations for prostate hypofractionation in the developing world | Nature Reviews Urology
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline | Journal of Clinical Oncology
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline | Journal of Clinical Oncology
No need to endure 38 to 44 treatments with IMRT anymore | THE "NEW" PROSTATE CANCER INFOLINK
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline | Journal of Clinical Oncology
A) Anorectal dose constraints with a correction to 2-Gy-per-fraction... | Download Scientific Diagram
Organ at risk dose constraint guide | Download Scientific Diagram
Supplementary appendix
Phase two EBRT component dose constraints | Download Table
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline | Journal of Clinical Oncology
Frontiers | Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
